跳至主要内容
临床试验/NCT03391414
NCT03391414已完成1 期

Effects of Inhaled Bicarbonate on Airway pH in Cystic Fibrosis

Joseph Pilewski2 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2014年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
12
试验地点
2
主要终点
Exhaled breath condensate pH change

研究概览

简要总结

This study will compare the use of inhaled concentrated sodium chloride solution to an inhaled solution of sodium bicarbonate in an attempt to decrease the thickness and stickiness of the mucus in the lungs of a person with cystic fibrosis. Also, this study is also looking at whether or not it is possible to decrease the acidity of the airways by inhaling sodium bicarbonate through nebulizer treatments.

详细描述

This study will compare the use of inhaled concentrated sodium chloride solution to an inhaled solution of sodium bicarbonate in an attempt to decrease the thickness and stickiness of the mucus in the lungs of a person with cystic fibrosis. Also, this study is also looking at whether or not it is possible to decrease the acidity of the airways by inhaling sodium bicarbonate through nebulizer treatments.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
None

入排标准

年龄范围
12 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • FEV1 greater than 50% predicted.
  • Ability to spontaneously expectorate sputum (with or without chest physiotherapy).
  • Stable disease as defined by absence of exclusion criteria numbers 3-5 and clinician assessment.

排除标准

  • Reactive airway disease
  • Use of inhaled hypertonic saline in the past 28 days
  • Use of IV antibiotics in the past 4 weeks
  • Changes in CF-related medications in the four weeks prior to study screening
  • SpO2 < 94% on room air or use of supplemental oxygen.
  • Presence of untreated gastroesophageal reflux disease (GERD) or residual acid reflux symptoms in cases of treated GERD more than three times per week.
  • Pregnant or nursing females.

研究组 & 干预措施

hypertonic bicarbonate

Experimental

subjects will be administered a solution of 8.4% hypertonic bicarbonate by nebulizer

干预措施: hypertonic bicarbonate (Drug)

hypertonic saline

Active Comparator

subjects will be administered a solution of 7% sodium chloride by nebulizer

干预措施: sodium chloride (Drug)

结局指标

主要结局

Exhaled breath condensate pH change

时间窗: two time points (baseline and four (4) hours)

Change in pH after inhalation of two doses on one day

次要结局

  • Expectorated sputum change(two time points (Baseline and four (4) hours))
  • Spirometry(two time points (baseline and four (4) hours))

研究者

发起方
Joseph Pilewski
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Joseph Pilewski

Associate Professor of Medicine and Pediatrics

University of Pittsburgh

研究点 (2)

Loading locations...

相似试验